AAPL346.95+3.04 (+0.88%) ▲|ABBV286.48-0.26 (-0.09%) ▼|ABT103.40-1.48 (-1.41%) ▼|ACN236.25-10.98 (-4.44%) ▼|ADBE251.12-7.50 (-2.90%) ▼|AMAT398.08+10.49 (+2.71%) ▲|AMD558.56+27.28 (+5.13%) ▲|AMGN447.01+2.38 (+0.53%) ▲|AMT185.93-2.35 (-1.25%) ▼|AMZN253.31+4.22 (+1.69%) ▲|AVGO341.61+12.44 (+3.78%) ▲|AXP314.18-0.88 (-0.28%) ▼|BA169.85-18.46 (-9.80%) ▼|BAC50.60+0.08 (+0.16%) ▲|BKNG151.78-1.36 (-0.89%) ▼|BLK1,134.93+7.27 (+0.64%) ▲|BMY61.34-0.27 (-0.44%) ▼|BNY147.83+0.65 (+0.44%) ▲|BRK-B544.77-3.79 (-0.69%) ▼|C122.63+1.59 (+1.31%) ▲|CAT712.52+20.39 (+2.95%) ▲|CL92.17-0.94 (-1.00%) ▼|CMCSA21.88-0.18 (-0.79%) ▼|COF204.42+2.07 (+1.02%) ▲|COP148.36-3.01 (-1.99%) ▼|COST991.31-13.86 (-1.38%) ▼|CRM243.11-4.51 (-1.82%) ▼|CSCO112.51+2.27 (+2.05%) ▲|CVS91.79-0.74 (-0.80%) ▼|CVX228.00-4.01 (-1.73%) ▼|DE642.51+1.26 (+0.20%) ▲|DHR232.24-0.73 (-0.31%) ▼|DIS109.57-0.83 (-0.75%) ▼|DUK124.02-0.42 (-0.33%) ▼|EMR164.59+2.89 (+1.79%) ▲|FDX304.59+4.01 (+1.33%) ▲|GD356.19-0.86 (-0.24%) ▼|GE295.92+7.49 (+2.60%) ▲|GEV878.92+24.30 (+2.84%) ▲|GILD157.49-1.21 (-0.76%) ▼|GM81.00+4.69 (+6.15%) ▲|GOOG318.16+3.97 (+1.26%) ▲|GOOGL321.77+4.97 (+1.57%) ▲|GS913.08+19.80 (+2.22%) ▲|HD318.22-1.16 (-0.36%) ▼|HON217.13-2.15 (-0.98%) ▼|IBM249.61-3.83 (-1.51%) ▼|INTC93.99+3.52 (+3.89%) ▲|INTU327.03-12.86 (-3.78%) ▼|ISRG444.77-6.86 (-1.52%) ▼|JNJ267.72+1.42 (+0.53%) ▲|JPM336.11+2.07 (+0.62%) ▲|KO92.13-0.57 (-0.61%) ▼|LIN506.81-0.75 (-0.15%) ▼|LLY1,284.53+5.39 (+0.42%) ▲|LMT628.47-6.73 (-1.06%) ▼|LOW197.14-1.09 (-0.55%) ▼|LRCX241.03+3.53 (+1.49%) ▲|MA610.28-3.22 (-0.52%) ▼|MCD248.78-2.06 (-0.82%) ▼|MDLZ62.30-0.67 (-1.06%) ▼|MDT93.80-0.99 (-1.04%) ▼|META624.85-5.71 (-0.91%) ▼|MMM171.51-1.28 (-0.74%) ▼|MO73.36-0.26 (-0.35%) ▼|MRK142.17+1.56 (+1.11%) ▲|MS187.21+3.72 (+2.03%) ▲|MSFT533.73+1.13 (+0.21%) ▲|MU931.42+27.72 (+3.07%) ▲|NEE82.05+0.01 (+0.01%) ▲|NFLX62.71-1.19 (-1.86%) ▼|NKE37.46-0.46 (-1.20%) ▼|NOW155.95-2.24 (-1.41%) ▼|NVDA218.70+2.70 (+1.25%) ▲|ORCL131.76+5.70 (+4.52%) ▲|PEP133.87-1.59 (-1.17%) ▼|PFE29.72-0.08 (-0.25%) ▼|PG158.48-1.44 (-0.90%) ▼|PLTR201.02+2.18 (+1.10%) ▲|PM203.69+1.82 (+0.90%) ▲|QCOM181.20+1.60 (+0.89%) ▲|RTX195.90-1.58 (-0.80%) ▼|SBUX102.49-0.21 (-0.20%) ▼|SCHW89.61-0.12 (-0.13%) ▼|SO91.87-0.70 (-0.76%) ▼|SPG212.30-0.40 (-0.19%) ▼|T21.07+0.22 (+1.03%) ▲|TMO692.74+7.85 (+1.15%) ▲|TMUS146.97+0.04 (+0.03%) ▲|TSLA406.15+14.53 (+3.71%) ▲|TXN306.47+8.35 (+2.80%) ▲|UBER66.13+0.00 (+0.00%) ▲|UNH409.51-1.20 (-0.29%) ▼|UNP297.85+0.88 (+0.29%) ▲|UPS103.36+3.04 (+3.03%) ▲|USB59.74+0.04 (+0.06%) ▲|V400.76-3.40 (-0.84%) ▼|VZ43.84+0.74 (+1.72%) ▲|WFC82.61-0.04 (-0.05%) ▼|WMT118.94-1.36 (-1.13%) ▼|XOM181.09-3.46 (-1.87%) ▼|AAPL346.95+3.04 (+0.88%) ▲|ABBV286.48-0.26 (-0.09%) ▼|ABT103.40-1.48 (-1.41%) ▼|ACN236.25-10.98 (-4.44%) ▼|ADBE251.12-7.50 (-2.90%) ▼|AMAT398.08+10.49 (+2.71%) ▲|AMD558.56+27.28 (+5.13%) ▲|AMGN447.01+2.38 (+0.53%) ▲|AMT185.93-2.35 (-1.25%) ▼|AMZN253.31+4.22 (+1.69%) ▲|AVGO341.61+12.44 (+3.78%) ▲|AXP314.18-0.88 (-0.28%) ▼|BA169.85-18.46 (-9.80%) ▼|BAC50.60+0.08 (+0.16%) ▲|BKNG151.78-1.36 (-0.89%) ▼|BLK1,134.93+7.27 (+0.64%) ▲|BMY61.34-0.27 (-0.44%) ▼|BNY147.83+0.65 (+0.44%) ▲|BRK-B544.77-3.79 (-0.69%) ▼|C122.63+1.59 (+1.31%) ▲|CAT712.52+20.39 (+2.95%) ▲|CL92.17-0.94 (-1.00%) ▼|CMCSA21.88-0.18 (-0.79%) ▼|COF204.42+2.07 (+1.02%) ▲|COP148.36-3.01 (-1.99%) ▼|COST991.31-13.86 (-1.38%) ▼|CRM243.11-4.51 (-1.82%) ▼|CSCO112.51+2.27 (+2.05%) ▲|CVS91.79-0.74 (-0.80%) ▼|CVX228.00-4.01 (-1.73%) ▼|DE642.51+1.26 (+0.20%) ▲|DHR232.24-0.73 (-0.31%) ▼|DIS109.57-0.83 (-0.75%) ▼|DUK124.02-0.42 (-0.33%) ▼|EMR164.59+2.89 (+1.79%) ▲|FDX304.59+4.01 (+1.33%) ▲|GD356.19-0.86 (-0.24%) ▼|GE295.92+7.49 (+2.60%) ▲|GEV878.92+24.30 (+2.84%) ▲|GILD157.49-1.21 (-0.76%) ▼|GM81.00+4.69 (+6.15%) ▲|GOOG318.16+3.97 (+1.26%) ▲|GOOGL321.77+4.97 (+1.57%) ▲|GS913.08+19.80 (+2.22%) ▲|HD318.22-1.16 (-0.36%) ▼|HON217.13-2.15 (-0.98%) ▼|IBM249.61-3.83 (-1.51%) ▼|INTC93.99+3.52 (+3.89%) ▲|INTU327.03-12.86 (-3.78%) ▼|ISRG444.77-6.86 (-1.52%) ▼|JNJ267.72+1.42 (+0.53%) ▲|JPM336.11+2.07 (+0.62%) ▲|KO92.13-0.57 (-0.61%) ▼|LIN506.81-0.75 (-0.15%) ▼|LLY1,284.53+5.39 (+0.42%) ▲|LMT628.47-6.73 (-1.06%) ▼|LOW197.14-1.09 (-0.55%) ▼|LRCX241.03+3.53 (+1.49%) ▲|MA610.28-3.22 (-0.52%) ▼|MCD248.78-2.06 (-0.82%) ▼|MDLZ62.30-0.67 (-1.06%) ▼|MDT93.80-0.99 (-1.04%) ▼|META624.85-5.71 (-0.91%) ▼|MMM171.51-1.28 (-0.74%) ▼|MO73.36-0.26 (-0.35%) ▼|MRK142.17+1.56 (+1.11%) ▲|MS187.21+3.72 (+2.03%) ▲|MSFT533.73+1.13 (+0.21%) ▲|MU931.42+27.72 (+3.07%) ▲|NEE82.05+0.01 (+0.01%) ▲|NFLX62.71-1.19 (-1.86%) ▼|NKE37.46-0.46 (-1.20%) ▼|NOW155.95-2.24 (-1.41%) ▼|NVDA218.70+2.70 (+1.25%) ▲|ORCL131.76+5.70 (+4.52%) ▲|PEP133.87-1.59 (-1.17%) ▼|PFE29.72-0.08 (-0.25%) ▼|PG158.48-1.44 (-0.90%) ▼|PLTR201.02+2.18 (+1.10%) ▲|PM203.69+1.82 (+0.90%) ▲|QCOM181.20+1.60 (+0.89%) ▲|RTX195.90-1.58 (-0.80%) ▼|SBUX102.49-0.21 (-0.20%) ▼|SCHW89.61-0.12 (-0.13%) ▼|SO91.87-0.70 (-0.76%) ▼|SPG212.30-0.40 (-0.19%) ▼|T21.07+0.22 (+1.03%) ▲|TMO692.74+7.85 (+1.15%) ▲|TMUS146.97+0.04 (+0.03%) ▲|TSLA406.15+14.53 (+3.71%) ▲|TXN306.47+8.35 (+2.80%) ▲|UBER66.13+0.00 (+0.00%) ▲|UNH409.51-1.20 (-0.29%) ▼|UNP297.85+0.88 (+0.29%) ▲|UPS103.36+3.04 (+3.03%) ▲|USB59.74+0.04 (+0.06%) ▲|V400.76-3.40 (-0.84%) ▼|VZ43.84+0.74 (+1.72%) ▲|WFC82.61-0.04 (-0.05%) ▼|WMT118.94-1.36 (-1.13%) ▼|XOM181.09-3.46 (-1.87%) ▼|
14.6 C
New York
Tuesday, October 27, 2026

Tag: patient

newsFORsourcecompanycontentinformation1releasesmarket

Akeso Announces First Patient Enrolled in the Phase III Trial（AK112-312/HARMONi-GI6）of Ivonescimab for First-Line Treatment of Advanced Metastatic Colorectal Cancer

HONG KONG, July 15, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is pleased to announce that the first patient has been successfully...

PHASE Scientific Expands INDICAID® Respiratory Portfolio with Exclusive U.S. Launch of Novel FebriDx® Test

FebriDx® is a first-in-class rapid test that differentiates between bacterial and non-bacterial respiratory infections, offering significant potential to address critical unmet needs in patient...

Barrett Family Foundation Makes Historic Gift to Help Build Extraordinary in Healthcare

TORONTO, July 15, 2025 (GLOBE NEWSWIRE) -- In a defining moment for healthcare, the Barrett Family Foundation has made a transformative donation to St. Joseph’s Health Centre—part of Unity Health Toronto—to create the Barrett Centre for Quality Improvement (BCQI). This incredible act of generosity enables one of the most ambitious quality improvement programs ever undertaken at a Canadian hospital.

BIOVAXYS ANNOUNCES EXTENSION OF OFFERING CLOSING DATE

// NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES // VANCOUVER, BC, July 15, 2025 /PRNewswire/ -- BioVaxys...

BIOVAXYS ANNOUNCES EXTENSION OF OFFERING CLOSING DATE

// NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES // VANCOUVER, BC, July 15, 2025 /CNW/ -- BioVaxys...

Menin Inhibitors Market Forecasts Signal Strong Uptake of Menin Inhibitors in Hematologic Oncology Across the 7MM During the Forecast Period (2020-2034) | DelveInsight

The menin inhibitor market is poised for rapid growth, with REVUFORJ setting the foundation and a strong pipeline of innovative, genetically targeted therapies on...

Menin Inhibitors Market Forecasts Signal Strong Uptake of Menin Inhibitors in Hematologic Oncology Across the 7MM During the Forecast Period (2020-2034) | DelveInsight

The menin inhibitor market is poised for rapid growth, with REVUFORJ setting the foundation and a strong pipeline of innovative, genetically targeted therapies on...

Globus Medical Introduces DuraPro™ with Navigation, a Next-Generation, Oscillating System Designed to Safeguard Delicate Tissue

AUDUBON, Pa., July 15, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced the expanded Excelsius™ navigation capabilities of its next-generation oscillating system, DuraPro™, as the latest addition to the Power Portfolio, designed to advance procedural workflows through safety features and efficiency.

Dr. Zachary Solomon Launches National Medical Tech Grant to Drive Healthcare Innovation Among U.S. Undergraduates

PHILADELPHIA, July 15, 2025 (GLOBE NEWSWIRE) -- Renowned cardiothoracic surgeon Dr. Zachary Solomon has officially announced the launch of the Dr. Zachary Solomon Medical Tech Grant, a prestigious academic initiative aimed at cultivating future leaders in medical technology and healthcare innovation. This national grant, open to undergraduate students across the United States, is designed to support aspiring professionals who are passionate about revolutionizing patient care through technology.

AZ Integrative & Functional Medicine Offering EXOMIND: Trailblazing Technology Using Brain Stimulation for Depression and Optimize Mental Health

EXOMIND launch event slated for July 25 SCOTTSDALE, Ariz., July 15, 2025 /PRNewswire/ -- For those seeking to lessen their anxiety, treat depression or enhance...

New Bass Center Clinic and Infusion Center to Facilitate Healing

PALO ALTO, Calif., July 15, 2025 /PRNewswire/ -- Lucile Packard Children's Hospital Stanford, the cornerstone of Stanford Medicine Children's Health, is proud to announce...

Les Laboratoires de Chalk River deviennent les premiers laboratoires certifiés BPL au Canada à offrir des études radiopharmaceutiques précliniques

Après avoir passé avec succès une vérification par le CCN, les LNC sont désormais prêts à mener des études précliniques pour l’industrie radiopharmaceutique en pleine croissance en tant que laboratoire qui respecte les bonnes pratiques de laboratoire (BPL) 
Après avoir passé avec succès une vérification par le CCN, les LNC sont désormais prêts à mener des études précliniques pour l’industrie radiopharmaceutique en pleine croissance en tant que laboratoire qui respecte les bonnes pratiques de laboratoire (BPL)

AscellaHealth’s Patient-Focused Approach is Best-in-Class Model for Distribution of Rare Disease Therapies

AscellaHealth’s Patient-Focused Approach is Best-in-Class Model for Distribution of Rare Disease Therapies

Made Scientific and Sentinel BioTherapeutics Announce Strategic Manufacturing Partnership to Advance Ph I/II Allogeneic ePP Encapsulated Cell Therapy Program

PRINCETON, N.J. and HOUSTON, July 15, 2025 /PRNewswire/ -- Made Scientific, a leading U.S.-based cell therapy contract development and manufacturing organization (CDMO), and Sentinel...

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsPatient

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers